Search results
Pfizer to Cut Costs in Multi-Year Effort
The Wall Street Journal· 3 days agoPfizer is launching a multi-year cost reduction program expected to include operational efficiencies, network structure changes, and product portfolio...
3 Things You Need to Know If You Buy Novavax Today
Motley Fool via Yahoo Finance· 4 days agovaccine didn't enter the market until after the inoculations developed by Moderna and Pfizer had already taken dominant market shares. This meant it...
Pfizer Unusual Options Activity - Pfizer (NYSE:PFE)
Benzinga· 5 days agoWhile it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal ...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 4 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
Century-old vaccine found to protect type 1 diabetics from infectious diseases
Medical Xpress· 3 days agoTwo back-to-back randomized double-blinded placebo-controlled trials found that the BCG vaccine provided continuous protection for nearly the entire COVID
Sarasota hospital board bucks Ladapo's claims against COVID-19 vaccines
WUSF 89.7· 4 days agoSarasota Memorial Health Care System will not endorse Florida Surgeon General Joseph Ladapo's guidance against COVID-19 vaccines on its website, as one ...
Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now
Motley Fool via Yahoo Finance· 5 days agoThis precipitous decline came after a period of immense operating success for the company. PFE...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
The Motley Fool via AOL· 1 day ago(That's no accident, because a falling stock price will boost a dividend yield, and vice versa, and Pfizer's stock was recently down 29% from its 52-week high.) Pfizer ...
Pfizer (NYSE:PFE) Shares Up 2%
ETF DAILY NEWS· 2 days agoPfizer Inc. (NYSE:PFE – Get Free Report)’s share price was up 2% during trading on Wednesday . The stock traded as high as $29.18 and last traded at $29.13. Approximately ...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 6 days agoNovavax is still developing a COVID-19/flu combination vaccine. It plans to start a phase 3 trial in...
